首页> 美国卫生研究院文献>Molecules >Novel 3-Acetyl-25-disubstituted-134-oxadiazolines: Synthesis and Biological Activity
【2h】

Novel 3-Acetyl-25-disubstituted-134-oxadiazolines: Synthesis and Biological Activity

机译:新型3-乙酰基-25-二取代-134-恶二唑啉:合成和生物活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of our study was the two-stage synthesis of 1,3,4-oxadiazole derivatives. The first step was the synthesis of hydrazide–hydrazones from 3-methyl-4-nitrobenzhydrazide and the corresponding substituted aromatic aldehydes. Then, the synthesized hydrazide–hydrazones were cyclized with acetic anhydride to obtain new 3-acetyl-2,3-disubstituted-1,3,4-oxadiazolines. All of obtained compounds were tested in in vitro assays to establish their potential antimicrobial activity and cytotoxicity. Our results indicated that few of the newly synthesized compounds had some antimicrobial activity, mainly compounds 20 and 37 towards all used reference bacterial strains (except Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa) and fungi. These substances showed a strong or powerful bactericidal effect, especially against Staphylococcus spp. belonging to Gram-positive bacteria. Compound 37 was active against Staphylococcus epidermidis at minimal inhibitory concentration (MIC) = 0.48 µg/mL and was characterized by low cytotoxicity. This compound possessed quinolin-4-yl substituent in the second position of 1,3,4-oxadiazole ring and 3-methyl-4-nitrophenyl in position 5. High effectiveness and safety of these derivatives make them promising candidates as antimicrobial agents. Whereas the compound 20 with the 5-iodofurane substituent in position 2 of the 1,3,4-oxadiazole ring showed the greatest activity against S. epidermidis at MIC = 1.95 µg/mL.
机译:我们的研究目的是1,3,4-氧代唑衍生物的两级合成。第一步是从3-甲基-4-硝基苯基肼和相应的取代芳族醛合成酰肼 - 腙。然后,将合成的酰肼 - 腙用乙酸酐环化,得到新的3-乙酰基-2,3-二取代的-1,3,4-恶二唑。所有得到的化合物在体外测定中测试以建立其潜在的抗微生物活性和细胞毒性。我们的研究结果表明,新合成的化合物中有很少有一些抗微生物活性,主要是化合物20和37,朝向所有使用的参考细菌菌株(Klebsiella Pneumoniae,Proteus mirabilis和Pseudomonas Aeruginosa)和真菌。这些物质显示出强烈或强大的杀菌效果,特别是对葡萄球菌SPP。属于革兰氏阳性细菌。化合物37在最小抑制浓度(MIC)=0.48μg/ mL的下含有葡萄球菌表皮的活性,并以低细胞毒性为特征。该化合物具有喹啉-4-基取代基在1,3,4-二唑环的第二位置和3-甲基-4-硝基苯基的位置5.这些衍生物的高效力和安全使其成为抗微生物剂的候选物。虽然1,3,4-氧基唑环的3〜碘尿核取代基的化合物20在MIC =1.95μg/ ml下针对对β的ePidermidis进行了最大的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号